Does a breathing strategy that helps during an operation also help the lungs recover afterward? A recently published PROBESE substudy offers a caution against assuming the two are interchangeable. Among 44 adults with obesity who had postoperative breathing tests, a higher-pressure ventilation strategy did not produce a clear improvement in next-day lung function compared with the lower-pressure strategy.
The BJA Open paper was published on September 30, 2026. Its participants underwent surgery years earlier, between May 2015 and August 2017. This is new reporting of an older trial subgroup, not a newly completed trial or a change in treatment approval.
What “higher pressure” meant in this study
During general anesthesia, a ventilator supports breathing. Positive end-expiratory pressure, or PEEP, maintains pressure at the end of an exhalation to help keep lung units open. Recruitment maneuvers briefly increase inflation to reopen collapsed areas. Those physiological aims do not automatically establish better recovery after the breathing tube is removed.
The Ghent University Hospital substudy compared PEEP of 12 cm H2O with recruitment maneuvers against PEEP of 4 cm H2O without routine recruitment maneuvers. Both groups received low tidal volumes: 7 mL per kilogram of predicted body weight. These are descriptions of the research protocol, not settings for readers to request or adjust. The study compared two combined strategies; it cannot isolate the effect of pressure from the effect of the maneuvers.
Participants had a BMI of at least 35 and underwent abdominal surgery, predominantly laparoscopic procedures. They were selected from patients at intermediate or high risk of postoperative pulmonary complications. That narrow setting matters: the findings should not be transferred to every person with obesity, every operation or intensive-care ventilation. Our BMI and health explainer discusses the limits of using a body-size category as a complete description of health.
The next-day result—and the uncertainty around it
The main measurement was FEV1, the volume of air a person can forcibly exhale in one second. Researchers compared its change from before surgery to postoperative day one. Of 48 enrolled participants, 44 had postoperative spirometry: 21 in the higher-PEEP group and 23 in the lower-PEEP group.
Average FEV1 fell by about 0.9 liters in each group. The reported between-group effect rounded to 0.0 liters, with a 95% confidence interval from −0.4 to 0.4 liters and P=0.89. A baseline-adjusted sensitivity analysis also found no statistically significant difference. Other breathing-test outcomes and the change in daytime oxygen saturation showed no clear advantage for either strategy. These results come from the substudy’s results and methods.
That is evidence against assuming a demonstrated next-day benefit. It is not proof that the strategies are equivalent. The interval still spans differences in either direction, and the small sample limits precision. Nor does a one-day reduction in a breathing-test measurement, by itself, establish permanent lung damage.
Why the endpoint moved from day five to day one
The study originally planned its primary assessment for postoperative day five. Many participants had already gone home by then, leaving too few measurements. Investigators changed the main time point to day one before analyzing the spirometry outcomes or reviewing group-specific results, but treatment allocation was already known.
This deserves attention because the sample-size calculation was based on day-five results from earlier research. The substudy was not specifically powered for its eventual day-one comparison. Four participants without postoperative spirometry were excluded, and missing values were not imputed. Later measurements were treated as exploratory and descriptive as data became sparse and uneven between groups.
People remaining in hospital may also differ from those discharged earlier. A later average therefore need not describe the recovery of the original full group. Oxygen saturation was checked intermittently during the day, so these measurements cannot rule out nighttime problems. These are concrete reasons to read beyond a headline saying “no difference.” Our guide to reading clinical trials explains why endpoints, denominators and missing data change the strength of a conclusion.
How this fits with the larger PROBESE trial
The parent trial asked a more directly clinical question: did the strategy reduce pulmonary complications within five days? Its 2019 JAMA report described 2,013 randomized participants, with 1,976 completing the trial. Complications occurred in 21.3% of the higher-PEEP group and 23.6% of the lower-PEEP group, without a statistically significant difference. The higher-pressure group had fewer low-oxygen episodes during surgery.
The new substudy adds a physiological recovery measure; it does not replace the parent trial’s clinical endpoint or provide an independent replication, because its participants came from that trial. The registry records study completion in May 2018. Keeping those dates and outcomes separate avoids turning a newly indexed paper into a new treatment breakthrough. For interpreting the parent trial’s percentages, see relative versus absolute risk.
What a patient can usefully take to a surgery discussion
The practical message is to ask about the whole breathing and recovery plan, rather than equating a higher ventilator setting with greater protection. Useful questions include which respiratory risks the team has identified, how breathing will be monitored after surgery, and what recovery instructions apply to the planned procedure. The study does not establish one universal ventilator setting.
It also did not test weight-loss medicines or whether to pause them. Those questions belong in a separate medication discussion; our GLP-1 medicines before surgery guide addresses that different issue. Neither this paper nor its null result supports changing a medicine, home breathing device or perioperative plan without the treating team.



